World News: 14:00 GMT Monday 4th June 2018. [Agios Pharmaceuticals, Inc. via Globe Newswire via SPi World News]
CHICAGO June 04 2018 GLOBE NEWSWIRE -- Agios Pharmaceuticals Inc NASDAQAGIO a leader in the field of cellular metabolism to treat cancer and rare genetic diseases today presented encouraging new data from a Phase 1 study evaluating ivos idenib ...
Globe Newswire: 14:00 GMT Monday 4th June 2018
SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2019. [Admin Only]
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 07519380.